SCHEMBL492195

SCHEMBL492195

CC(=O)N[N+](=O)[O-]

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Ammonia Solution, Strong SCHEMBL9456290 0.97
SCHEMBL14128906 0.73
SCHEMBL17874638 0.73
SCHEMBL327059 0.71
SCHEMBL4201308 0.71
SCHEMBL8533882 0.71
SCHEMBL4206830 0.69
Potassium Ion SCHEMBL4206827 0.69
Ammonia Solution, Strong SCHEMBL8665452 0.69
SCHEMBL29993715 0.69 ALDH1A1 (0.39)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 58 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11518685-B2 Conversion of ammonium nitrate into useful products SOUTHWEST RESEARCH INSTITUTE (US) 2022-12-06 US claimed
CN-107098850-A A kind of method for synthesizing the piperidones of 1 methyl, 3 nitro, 4 phenyl 2,6 2 西安近代化学研究所 2017-08-29 CN claimed
CN-101973907-B Method for preparing N-nitroacetamide XIAN MODERN CHEMISTRY RES INST 2013-04-03 CN claimed
CN-1083447-C Process for preparation of benzothiazolone compounds ASTRA PHARMA PROD (SE) 2002-04-24 CN claimed
CN-1248252-A Preparation method of benzothiazolone compound ASTRA PHARMA PROD (GB) 2000-03-22 CN claimed
US-11702427-B2 Substituted 2-pyridone tricyclic compounds, analogues thereof, and methods using same ARBUTUS BIOPHARMA CORPORATION (CA) 2023-07-18 US disclosed
US-11518685-B2 Conversion of ammonium nitrate into useful products SOUTHWEST RESEARCH INSTITUTE (US) 2022-12-06 US disclosed
WO-2021155412-A1 CONVERSION OF AMMONIUM NITRATE INTO USEFUL PRODUCTS SOUTHWEST RESEARCH INSTITUTE (US) 2021-08-05 WO disclosed
US-20210238047-A1 Conversion of Ammonium Nitrate Into Useful Products SOUTHWEST RESEARCH INSTITUTE 2021-08-05 US disclosed
US-20210017186-A1 SUBSTITUTED 2-PYRIDONE TRICYCLIC COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA CORPORATION (CA) 2021-01-21 US disclosed
WO-2019177937-A1 SUBSTITUTED 2-PYRIDONE TRICYCLIC COMPOUNDS, ANALOGUES THEREOF, AND METHODS USING SAME ARBUTUS BIOPHARMA, INC. (US) 2019-09-19 WO disclosed
US-20130217683-A1 INDAZOLES, BENZOTHIAZOLES, BENZOISOTHIAZOLES, BENZISOXAZOLES, AND PREPARATION AND USE THEREOF MEMORY PHARMACEUTICALS CORPORATION (US) 2013-08-22 US disclosed
EP-1074549-A2 Tetrahydro-benzo(d)azepines and their use as antagonists at metabotropic glutamate receptors F. HOFFMANN-LA ROCHE AG (CH) 2001-02-07 EP disclosed
JP-2001004833-A DYE-BASED POLARIZING FILM CONTAINING AZO COMPOUND SUMITOMO CHEM CO LTD 2001-01-12 JP disclosed
CN-1248252-A Preparation method of benzothiazolone compound ASTRA PHARMA PROD (GB) 2000-03-22 CN disclosed
EP-0509769-B1 Heterocyclic amides having HLE inhibiting activity ZENECA LTD (GB) 1996-09-11 EP disclosed
US-5521179-A Heterocyclic amides ZENECA LIMITED (GB) 1996-05-28 US disclosed
EP-0509769-A2 Heterocyclic amides having HLE inhibiting activity ZENECA LIMITED (GB) 1992-10-21 EP disclosed
CN-1062138-A The synergy of HIV reverse transcriptase inhibitors MERCK & CO INC (US) 1992-06-24 CN disclosed
EP-0481802-A1 Hydroxylated inhibitors of HIV reverse transcriptase MERCK & CO. INC. (US) 1992-04-22 EP disclosed